Zachary Leibovit-Reiben
Overview
Explore the profile of Zachary Leibovit-Reiben including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
4
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Coudray N, Juarez M, Criscito M, Claudio Quiros A, Wilken R, Jackson Cullison S, et al.
NPJ Digit Med
. 2025 Feb;
8(1):105.
PMID: 39955424
Primary cutaneous squamous cell carcinoma (cSCC) is responsible for ~10,000 deaths annually in the United States. Stratification of risk of poor outcome at initial biopsy would significantly impact clinical decision-making...
2.
Zhang N, Stockard A, Leibovit-Reiben Z, Hwang A, Kechter J, Brumfiel C, et al.
Arch Dermatol Res
. 2025 Feb;
317(1):413.
PMID: 39951132
Current validated lichen planus (LP) scoring systems are complicated and optimized for generalized, multi-site disease. There is a need for a validated, simple lesional assessment in LP. Herein, we repurpose...
3.
Nassir S, Yousif M, Li X, Severson K, Hughes A, Kechter J, et al.
J Invest Dermatol
. 2025 Jan;
PMID: 39884456
Cutaneous squamous cell carcinoma is one of the most common cancers in humans and kills as many people annually as melanoma. The understanding of the transcriptional changes with respect to...
4.
Leibovit-Reiben Z, Godfrey H, Jedlowski P, Thiede R
Melanoma Res
. 2024 Dec;
35(2):122-129.
PMID: 39656586
BRAF and MEK inhibitor (BRAFi + MEKi) therapy has improved the treatment of solid tumors with BRAF mutation. However, their neurologic adverse events (nAEs) have been largely unexplored. This study...
5.
Hwang A, Kechter J, Do T, Hughes A, Zhang N, Li X, et al.
J Clin Invest
. 2024 Nov;
135(2.
PMID: 39541169
BACKGROUNDCutaneous lichen planus (LP) is a recalcitrant, difficult-to-treat, inflammatory skin disease characterized by pruritic, flat-topped, violaceous papules on the skin. Baricitinib is an oral Janus kinase (JAK) 1/2 inhibitor that...
6.
Godfrey H, Leibovit-Reiben Z, Jedlowski P, Thiede R
J Am Acad Dermatol
. 2024 Aug;
91(6):1233-1234.
PMID: 39168310
No abstract available.
7.
Trivedi M, Dumkrieger G, Chong C, Leibovit-Reiben Z, Schwedt T
Headache
. 2024 Jul;
64(9):1109-1123.
PMID: 39051483
Background: Prior studies have established an association between a history of abuse and more severe migraine presentation. Objectives: This cross-sectional, observational study of a clinic-based migraine population used validated measures...
8.
Leibovit-Reiben Z, Godfrey H, Stanley A, Thiede R
Clin Dermatol
. 2024 Jun;
42(6):709-714.
PMID: 38944246
Derived from the survival advantage needed to eradicate harmful irritants from the skin's surface, itch, also known as pruritus, is an intriguing phenomenon and a key feature of many dermatologic...
9.
Godfrey H, Leibovit-Reiben Z, Jedlowski P, Thiede R
J Eur Acad Dermatol Venereol
. 2024 Jun;
39(2):e153-e154.
PMID: 38925559
No abstract available.
10.
Leibovit-Reiben Z, Dumkrieger G, Dodick D, Digre K, Chong C, Trivedi M, et al.
J Neuroophthalmol
. 2023 Aug;
44(2):259-266.
PMID: 37581595
Background: Photosensitivity, often called "photophobia" in the migraine literature, is a common and bothersome symptom for most people during their migraine attacks. This study aimed to investigate the association of...